Anaphylaxis to Subcutaneous Immunoglobulin in a Severe Combined Immunodeficiency Patient.

Authors :: Castano-Jaramillo LM
Toledo-Salinas C
Pardo-Diaz E
Contreras-Verduzco FA
Mendoza-Hernandez DA
Source :: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Oct; Vol. 61 (10), pp. 1386-1387. Date of Electronic Publication: 2021 Jun 14.
Publication Year :: 2021

Subjects :: Child
Hematopoietic Stem Cell Transplantation
Humans
Immunoglobulin G therapeutic use
Injections, Subcutaneous
Male
Anaphylaxis chemically induced
Immunoglobulin G adverse effects
Severe Combined Immunodeficiency drug therapy

Full Text Access

Tools